CAS 1352920-57-0

L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]-, 2,2,2-trifluoroacetate (1:1)

Description:

L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]-, 2,2,2-trifluoroacetate (1:1) is a complex organic compound characterized by its intricate structure, which includes multiple functional groups such as amides, hydroxyls, and trifluoroacetate moieties. This compound is likely to exhibit properties typical of amino acids and their derivatives, including potential solubility in polar solvents due to the presence of hydroxyl and amide groups. The trifluoroacetate component may enhance its stability and influence its reactivity. Given its structural complexity, it may also exhibit unique biological activities, potentially serving as a pharmaceutical intermediate or a research chemical. The presence of multiple chiral centers suggests that it may exist in different stereoisomeric forms, which could affect its biological interactions and pharmacokinetics. Overall, this compound represents a specialized class of organic molecules with potential applications in medicinal chemistry and biochemistry.

Formula: C₃₁H₅₂N₄O₇·C₂HF₃O₂

Synonyms:

• L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]-, 2,2,2-trifluoroacetate (1:1)

Gallinamide A TFA

CAS: 1352920-57-0

Gallinamide A TFA is a peptide that exhibits linear deposition and serves as a potent inhibitor of cathepsin L (CatL) with an IC50 of 17.6 pM. It inhibits SARS-CoV-2 infection by targeting CatL (EC50: 28 nM) and also inhibits Plasmodium falciparum with an IC50 of 50 nM [1] [2].

Formula: C₃₃H₅₃F₃N₄O₉

Color and Shape: Solid

Molecular weight: 706.79

Ref: TM-TN7689